
Keli L. Hill
Examiner (ID: 14362, Phone: (571)272-4375 , Office: P/2912 )
| Most Active Art Unit | 2912 |
| Art Unit(s) | 2912, 2922, 2952 |
| Total Applications | 3649 |
| Issued Applications | 3514 |
| Pending Applications | 12 |
| Abandoned Applications | 123 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5609322
[patent_doc_number] => 20060270838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Pantropic neurotrophic factors'
[patent_app_type] => utility
[patent_app_number] => 11/443576
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 21494
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270838.pdf
[firstpage_image] =>[orig_patent_app_number] => 11443576
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/443576 | Pantropic neurothrophic factors | May 29, 2006 | Issued |
Array
(
[id] => 5397325
[patent_doc_number] => 20090317388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'Tl1a in treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 11/921048
[patent_app_country] => US
[patent_app_date] => 2006-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13441
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317388.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921048 | Tl1a in treatment of disease | May 24, 2006 | Abandoned |
Array
(
[id] => 5689187
[patent_doc_number] => 20060287502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'C3b/C4b complement receptor-like molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/429673
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 29117
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429673
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429673 | C3b/C4b complement receptor-like molecules and uses thereof | May 4, 2006 | Abandoned |
Array
(
[id] => 5508574
[patent_doc_number] => 20090081781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Synthetic and standardized prion infectuous material, and uses thereof as an injecting inoculum'
[patent_app_type] => utility
[patent_app_number] => 11/919715
[patent_app_country] => US
[patent_app_date] => 2006-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6736
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081781.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919715
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919715 | Synthetic and standardized prion infectuous material, and uses thereof as an injecting inoculum | May 3, 2006 | Abandoned |
Array
(
[id] => 5682523
[patent_doc_number] => 20060198793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Antimicrobial polypeptide, nucleic acid, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/405763
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4365
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20060198793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405763
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405763 | Antimicrobial polypeptide, nucleic acid, and methods of use | Apr 17, 2006 | Abandoned |
Array
(
[id] => 4455601
[patent_doc_number] => 07892845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Methods for measuring the metabolism of neurally dervied biomolecules in vivo'
[patent_app_type] => utility
[patent_app_number] => 11/910463
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11127
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892845.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910463
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910463 | Methods for measuring the metabolism of neurally dervied biomolecules in vivo | Apr 3, 2006 | Issued |
Array
(
[id] => 1076704
[patent_doc_number] => 07615215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'Anti-human VEGF receptor Flt-1 monoclonal antibody'
[patent_app_type] => utility
[patent_app_number] => 11/277121
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 52
[patent_no_of_words] => 43628
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615215.pdf
[firstpage_image] =>[orig_patent_app_number] => 11277121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/277121 | Anti-human VEGF receptor Flt-1 monoclonal antibody | Mar 20, 2006 | Issued |
Array
(
[id] => 5367749
[patent_doc_number] => 20090305308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'METHOD FOR IDENTIFYING CELL-SPECIFIC PROTEIN COMBINATION PATTERNS'
[patent_app_type] => utility
[patent_app_number] => 11/909357
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4036
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305308.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909357
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909357 | METHOD FOR IDENTIFYING CELL-SPECIFIC PROTEIN COMBINATION PATTERNS | Mar 20, 2006 | Abandoned |
Array
(
[id] => 5631532
[patent_doc_number] => 20060148002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Methods and compositions for the treatment and diagnosis of body weight disorders'
[patent_app_type] => utility
[patent_app_number] => 11/370754
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28301
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11370754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/370754 | Methods and compositions for the treatment and diagnosis of body weight disorders | Mar 7, 2006 | Abandoned |
Array
(
[id] => 4859096
[patent_doc_number] => 20080267946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising an Antibody Against Tgf-Beta'
[patent_app_type] => utility
[patent_app_number] => 11/817023
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2837
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267946.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817023 | Pharmaceutical Composition for Treating Avellino Cornea Dystrophy Comprising an Antibody Against Tgf-Beta | Mar 7, 2006 | Abandoned |
Array
(
[id] => 5595760
[patent_doc_number] => 20060159676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Methods for modulating angiogenesis, lymphangiogenesis, and apoptosis with apelin compositions'
[patent_app_type] => utility
[patent_app_number] => 11/333830
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 20706
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159676.pdf
[firstpage_image] =>[orig_patent_app_number] => 11333830
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/333830 | Methods for modulating angiogenesis, lymphangiogenesis, and apoptosis with apelin compositions | Jan 16, 2006 | Abandoned |
Array
(
[id] => 5667065
[patent_doc_number] => 20060172415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Oligodendrocyte precursor cells and method of obtaining and culturing the same'
[patent_app_type] => utility
[patent_app_number] => 10/564819
[patent_app_country] => US
[patent_app_date] => 2006-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12182
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172415.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564819 | Oligodendrocyte precursor cells and method of obtaining and culturing the same | Jan 12, 2006 | Abandoned |
Array
(
[id] => 5672546
[patent_doc_number] => 20060177901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy'
[patent_app_type] => utility
[patent_app_number] => 11/327075
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 37965
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11327075
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/327075 | Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy | Jan 5, 2006 | Issued |
Array
(
[id] => 5655213
[patent_doc_number] => 20060140948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Fully human monoclonal antibodies to IL-13'
[patent_app_type] => utility
[patent_app_number] => 11/281266
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 39048
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140948.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281266
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281266 | Fully human monoclonal antibodies to IL-13 | Nov 15, 2005 | Issued |
Array
(
[id] => 5799305
[patent_doc_number] => 20060034838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Anti-human VEGF receptor Flt-1 monoclonal antibody'
[patent_app_type] => utility
[patent_app_number] => 11/250411
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 43524
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034838.pdf
[firstpage_image] =>[orig_patent_app_number] => 11250411
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/250411 | Anti-human VEGF receptor Flt-1 monoclonal antibody | Oct 16, 2005 | Issued |
Array
(
[id] => 4650993
[patent_doc_number] => 20080038249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a'
[patent_app_type] => utility
[patent_app_number] => 11/630076
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19210
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038249.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630076 | Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a | Sep 25, 2005 | Abandoned |
Array
(
[id] => 5010510
[patent_doc_number] => 20070280989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Compositions and Methods for Stem Cell Expansion and Differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/575618
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16361
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575618
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575618 | Compositions and Methods for Stem Cell Expansion and Differentiation | Sep 20, 2005 | Abandoned |
Array
(
[id] => 5699610
[patent_doc_number] => 20060216294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Method of modulation'
[patent_app_type] => utility
[patent_app_number] => 11/229415
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17368
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216294.pdf
[firstpage_image] =>[orig_patent_app_number] => 11229415
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/229415 | Method of modulation | Sep 15, 2005 | Abandoned |
Array
(
[id] => 5814018
[patent_doc_number] => 20060084117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Galphaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors'
[patent_app_type] => utility
[patent_app_number] => 11/227086
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4993
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084117.pdf
[firstpage_image] =>[orig_patent_app_number] => 11227086
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/227086 | Galphaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors | Sep 15, 2005 | Abandoned |
Array
(
[id] => 4888039
[patent_doc_number] => 20080262371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Method for Adaptive Complex Wavelet Based Filtering of Eeg Signals'
[patent_app_type] => utility
[patent_app_number] => 11/575447
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3190
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262371.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575447
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575447 | Method for Adaptive Complex Wavelet Based Filtering of Eeg Signals | Sep 15, 2005 | Abandoned |